Lorpucitinib

N/A

Report date: 2026/02/04 12:31:41
NME

Base Information

Drug NameLorpucitinib
Drug Alias NameJNJ-64251330JNJ-1330
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsAdenomatous Polyposis Coli
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesN/A
Active IndicationsAdenomatous Polyposis Coli
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A